申请人:Ciba-Geigy Corporation
公开号:US03941804A1
公开(公告)日:1976-03-02
Compounds of the class of 1-heteroarylsulphonyl-2-imino-imidazolidines which are substituted in the 3-position by an aliphatic or cycloaliphatic hydrocarbon radical, especially a cycloalkyl radical, and their pharmaceutically acceptable acid addition salts have valuable pharmacological properties. In particular, they possess hypoglycaemic activity and can be used for the treatment of hyperglycaemia in mammals. A specific embodiment is 1-[5-(2-butyramido-ethyl)-2-thienylsulphonyl]-2-imino-5-cyclohexyl-imidazo lidine.
1-杂环磺酰基-2-亚胺-咪唑啉类化合物,其在3位被脂肪或环脂烃基取代,特别是环烷基基团,以及它们的药学上可接受的酸盐具有宝贵的药理学性质。特别是,它们具有降糖活性,可用于治疗哺乳动物的高血糖。一个具体的实施例是1-[5-(2-丁酰胺基乙基)-2-噻吩基磺酰基]-2-亚胺-5-环己基咪唑啉。